Vaccine News and Research

Latest Vaccine News and Research

Canadian scientist discusses about how society could better prepare for future pandemics

Canadian scientist discusses about how society could better prepare for future pandemics

Study shows the mutations leading to omicron variant did not help virus escape recognition by T cells

Study shows the mutations leading to omicron variant did not help virus escape recognition by T cells

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

Study indicates a 100 µg mRNA-1273 booster has acceptable safety and robust antibody response against SARS-CoV-2

Study indicates a 100 µg mRNA-1273 booster has acceptable safety and robust antibody response against SARS-CoV-2

Updated results from ongoing study on the effect of a BNT162b2 booster dose on anti-SARS-CoV-2 antibodies

Updated results from ongoing study on the effect of a BNT162b2 booster dose on anti-SARS-CoV-2 antibodies

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Most cancer patients develop antibodies after receiving COVID-19 vaccine, study shows

Most cancer patients develop antibodies after receiving COVID-19 vaccine, study shows

Study shows vaccine effectiveness against SARS-CoV-2 and severe disease in dialysis patients

Study shows vaccine effectiveness against SARS-CoV-2 and severe disease in dialysis patients

Three vaccine doses are crucial to achieve effective protection against omicron

Three vaccine doses are crucial to achieve effective protection against omicron

KHN’s ‘What the Health?’: Congress shelves covid funding for now

KHN’s ‘What the Health?’: Congress shelves covid funding for now

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Incidence of myocarditis and pericarditis following COVID-19 vaccination

Incidence of myocarditis and pericarditis following COVID-19 vaccination

The trajectory of B-cell immunity six months after mRNA vaccination

The trajectory of B-cell immunity six months after mRNA vaccination

WVU researchers use machine learning and GIS to predict where COVID-19 testing will be most crucial

WVU researchers use machine learning and GIS to predict where COVID-19 testing will be most crucial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.